Article
Bcl-2 reduces lymphomagenesis in deltaV-TCRbeta transgenic mice.
Oncogene - 29 May 1997
Acton D, Jacobs H, Domen J, Berns A
Abstract excerpt
Overexpression of the bcl-2 oncogene in the lymphoid compartment of transgenic mice prolongs the lifespan of lymphocytes and leads to a low incidence of lymphomas at later age. Transgenic mice carrying a mutated T-cell receptor lacking the variable domain (deltaV-TCRbeta) suffer from lymphocyte depletion and are highly predisposed to lymphoma development. We intercrossed Bcl-2-Ig and deltaV-TCRbeta transgenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
